Capital International Investors Novo Cure LTD Transaction History

Capital International Investors

$488 Billion
Q1 2025

A detailed history of Capital International Investors transactions in Novo Cure LTD stock. As of the latest transaction made, Capital International Investors holds 8,945,166 shares of NVCR stock, worth $166 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,945,166

Previous 8,873,902 0.8%

Holding current value

$166 Million

Previous $264 Million 39.72%

% of portfolio

0.03%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$17.82 - $30.19 $1.27 Million - $2.15 Million	71,264 Added 0.8%	8,945,166 $159 Million
Q4 2024 Feb 13, 2025	BUY	$14.54 - $33.41 $13.8 Million - $31.8 Million	951,141 Added 12.01%	8,873,902 $264 Million
Q3 2024 Nov 13, 2024	SELL	$15.61 - $23.34 $58.9 Million - $88.1 Million	-3,773,587 Reduced 32.26%	7,922,761 $124 Million
Q2 2024 Aug 13, 2024	BUY	$11.83 - $24.05 $33.5 Million - $68.1 Million	2,832,256 Added 31.95%	11,696,348 $200 Million
Q1 2024 May 14, 2024	BUY	$12.42 - $17.29 $27,584 - $38,401	2,221 Added 0.03%	8,864,092 $139 Million
Q4 2023 Feb 13, 2024	SELL	$11.13 - $15.78 $1.59 Million - $2.25 Million	-142,621 Reduced 1.58%	8,861,871 $132 Million
Q3 2023 Nov 13, 2023	BUY	$16.15 - $42.35 $3.16 Million - $8.28 Million	195,560 Added 2.22%	9,004,492 $145 Million
Q2 2023 Aug 11, 2023	BUY	$40.29 - $82.51 $46.7 Million - $95.7 Million	1,159,945 Added 15.16%	8,808,932 $366 Million
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $17.1 Million - $36 Million	-302,661 Reduced 3.81%	7,648,987 $460 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $2.24 Million - $2.99 Million	35,013 Added 0.44%	7,951,648 $583 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $99,945 - $131,667	1,470 Added 0.02%	7,916,635 $602 Million
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $194 Million - $308 Million	-3,429,861 Reduced 30.23%	7,915,165 $550 Million
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $783,213 - $1.1 Million	13,021 Added 0.11%	11,345,026 $940 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $58.2 Million - $94.6 Million	775,189 Added 7.34%	11,332,005 $851 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $164 Million - $275 Million	1,413,074 Added 15.45%	10,556,816 $1.23 Billion
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $3.41 Million - $5.89 Million	26,118 Added 0.29%	9,143,742 $2.03 Billion
Q1 2021 May 14, 2021	BUY	$124.11 - $190.17 $107 Million - $164 Million	862,354 Added 10.45%	9,117,624 $1.21 Billion
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $6.36 Million - $9.87 Million	56,701 Added 0.69%	8,255,270 $1.43 Billion
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $273 Million - $524 Million	4,710,881 Added 135.07%	8,198,569 $913 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $53.3 Million - $69.3 Million	931,963 Added 36.47%	3,487,688 $207 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $67 Million - $113 Million	1,175,050 Added 85.11%	2,555,725 $172 Million
Q4 2019 Feb 18, 2020	BUY	$68.3 - $93.8 $50.2 Million - $68.9 Million	734,475 Added 113.66%	1,380,675 $116 Million
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $10.2 Million - $17.9 Million	318,900 Added 97.43%	646,200 $31.1 Million
Q4 2018 Feb 14, 2019	BUY	$28.72 - $52.63 $9.4 Million - $17.2 Million	327,300 New	327,300 $11 Million

Others Institutions Holding NVCR

# of Institutions

266

Shares Held

79.4M

Call Options Held

970K

Put Options Held

118K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.95B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Novo Cure LTD Transaction History